Clinical Trial Update: Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN) [Phase 2]

View source ↗

Summary

A Phase 2 dose-tolerability titration study to evaluate the efficacy and safety of Perampanel (E2007) in postherpetic neuralgia has been completed. The sponsor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Neuralgia | Phase 2 | Status: COMPLETED | Results posted: 2013-02-15